J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 August 2008

J Med Genet. Published Online First: 15 April 2008. doi:10.1136/jmg.2008.057729
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jmg.2008.057729v1
45/8/519    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kent, L.
Right arrow Articles by Yates, J. R.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kent, L.
Right arrow Articles by Yates, J. R.W.

Original articles

X linked ichthyosis (steroid sulphatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits

Lindsey Kent 1*, Jane Emerton 2, Vishu Bhadravathi 2, Emma Weisblatt 2, Greg Pasco 2, Lionel R Willatt 3, Robert McMahon 3 and John R.W. Yates 2

1 University of St Andrews, United Kingdom
2 University of Cambridge, United Kingdom
3 Addenbrookes NHS Trust, United Kingdom

* To whom correspondence should be addressed. E-mail: lsk8{at}st-andrews.ac.uk.

Accepted 19 March 2008


*   Abstract

Background: X linked ichthyosis (XLI) (steroid sulphatase deficiency) is caused by deletions or point mutations of the steroid sulphatase (STS) gene on chromosome Xp22.32. Deletions of this region can be associated with cognitive behavioural difficulties including autism and animal work suggests the STS gene may be involved in attentional processes. We have therefore undertaken a systematic study of autism and Attention Deficit Hyperactivity Disorder (ADHD) in boys with XLI.

Methods: Cases of XLI were recruited from families originally ascertained when pregnancies with STS deficiency were identified through a routine maternal screening programme. Boys with XLI were assessed for ADHD and autism using standardised questionnaires and interviews. Deletions of the STS gene were identified and characterised by analysis of genomic DNA and/or fluorescent in-situ hybridization.

Results: 73% of families approached agreed to participate in the study. 25 boys with XLI were assessed for autism and ADHD. 40% fulfilled DSM-IV criteria for a diagnosis of ADHD, 80% of which were inattentive subtype. ADHD diagnoses were present in those with both deletions and presumed point mutations of STS. Additionally, 5 boys, from 3 unrelated families fulfilled criteria for an autistic spectrum disorder or related language / communication difficulty, and all had an unusually large deletion of the STS gene, which also encompassed the neuroligin 4 (NLGN4) gene. None of the boys with the typical deletion or presumed point mutations of STS demonstrated autistic difficulties.

Conclusions: STS deficiency may be a risk factor for ADHD with predominantly inattentive symptoms. Boys with XLI and large deletions encompassing STS and NLGN4 are at an increased risk of developing autism and related disorders








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.